Skip to content
Market Tracked raises in 2026$3.41B+$183M this week Rounds76 LatestBlue J$176M Series E Tuesday, November 10

Parambil

Parambil is AI medical record review software for mass tort and complex litigation.

X1

X1 is the leader in index-in-place data discovery — and the only platform that runs AI In-Place directly where enterprise data lives. Game-changing software for eDiscovery, Governance, Risk and...

Parambil vs X1

At a Glance

DetailParambilX1
CategoryeDiscoveryeDiscovery
Total raised$8MNot disclosed
Rounds tracked2Not disclosed
Latest roundSeed, $6M · Jan 2026Not disclosed
Last valuationNot disclosedNot disclosed
Lead investorsBling Capital, Daybreak VenturesNot disclosed
Built forMid-size firms, BoutiquesNot disclosed
HeadquartersUnited StatesUS

Funding, Side by Side

Parambil$8M
X1Undisclosed
Parambil rounds
  1. Jan 2026Seed$6M
  2. Jan 2025Seed$2M
X1 rounds

No public rounds tracked yet.

Our Take

We have not tested these two head to head yet. The numbers above come from public funding announcements. If you use either one, tell us what you found and it may become a Field Note.

Quick Answers

Which has raised more, Parambil or X1?
Parambil has raised $8M in disclosed funding, compared with no disclosed amount for X1.
What is Parambil best for?
Parambil is AI medical record review software for mass tort and complex litigation.
What is X1 best for?
X1 is the leader in index-in-place data discovery — and the only platform that runs AI In-Place directly where enterprise data lives. Game-changing software for eDiscovery, Governance, Risk and.

Source: Legal Tech Circle funding data, from public announcements. Updated November 10, 2026.